MedTrace Logo

The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease

NCT06762509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-01-15

No results posted yet for this study

Summary

In order to expand the treatment of Wilson disease and improve the quality of life of patients with Wilson's disease, the clinical effect of botulinum toxin type A injection on Wilson's disease was discussed.

Conditions

  • Wilson Disease

Interventions

DRUG

Botulinum toxin type A

Local injection of botulinum toxin type A was given at the time of enrollment

Sponsors & Collaborators

  • The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2023-12-01
Completion
2024-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06762509 on ClinicalTrials.gov